Articles with "resistance cervical" as a keyword



Photo by art_almighty from unsplash

CircMYBL2 regulates the resistance of cervical cancer cells to paclitaxel via miR-665-dependent regulation of EGFR.

Sign Up to like & get
recommendations!
Published in 2021 at "Drug development research"

DOI: 10.1002/ddr.21834

Abstract: Circular RNAs are considered to be associated with cancer resistance. This study aims to investigate the function and mechanism of circMYBL2 in paclitaxel (PTX) resistance of cervical cancer (CC). The expression of circMYBL2, miR-665 and… read more here.

Keywords: egfr; mir 665; circmybl2; cancer ... See more keywords
Photo by nci from unsplash

miR‐144 reverses cisplatin resistance in cervical cancer via targeting LHX2

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Cellular Biochemistry"

DOI: 10.1002/jcb.28763

Abstract: Mounting evidence showed that microRNAs involve in development and chemoresistance of various human cancers. We explored the roles and mechanisms of miR‐144 in resistance to cisplatin (CDDP) of cervical cancer cells. miR‐144 and LIM homeobox… read more here.

Keywords: cell; mir 144; cervical cancer; resistance cervical ... See more keywords

The role of long noncoding RNAs in therapeutic resistance in cervical cancer

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Cell and Developmental Biology"

DOI: 10.3389/fcell.2022.1060909

Abstract: Cervical cancer is one of the common tumors and often causes cancer-related death in women. Chemotherapy is a common cancer therapy, which displays a pivotal clinical benefit for cancer patients. However, chemoresistance becomes a big… read more here.

Keywords: cervical cancer; resistance cervical; long noncoding; noncoding rnas ... See more keywords
Photo from wikipedia

Phenethylisothiocyanate Potentiates Platinum Therapy by Reversing Cisplatin Resistance in Cervical Cancer

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Pharmacology"

DOI: 10.3389/fphar.2022.803114

Abstract: Acquired cisplatin resistance in cervical cancer therapy is principally caused by reduction in intracellular drug accumulation, which is exerted by hyperactivation of the oncogenic PI3K/Akt signaling axis and overexpression of cisplatin-exporter MRP2 along with prosurvival… read more here.

Keywords: cervical cancer; resistance cervical; cancer; cisplatin resistance ... See more keywords